1 |
Lee HI, Kim YK, Lim HC, Lee DE, Kim EJ, Moon YH. Effects of Agastachis Herba Extract and Lysimachiae Herba Extract on the Experimental Cellular Model of NFLDs Induced by Palmitic Acid. The Journal of Internal Korean Medicine 2018;39(3):302-12.
DOI
|
2 |
Traditional Chinese Association. Guidelines for Diagnosis and Treatment of Common Internal Diseases in Chinese Medicine Diseases of Modern Medicine. Beijing: China Traditional China Medicine Publisher; 2008, p. 153.
|
3 |
Professors of Department of Internal Medicine of liver system, National College of Korean Medicine. Gangye Naegwahak. Seoul: Nado; 2013, p. 102-15, 321-8.
|
4 |
李文科, 陈文炎, 廖楠君, 李宇, 张闽光. 疏肝健脾通络法治疗单纯非酒精性脂肪肝疗效观察. 临床合理用药杂志 2018;11(22):60-1.
|
5 |
李润东, 张佩佩, 马宏涛, 李慧芳, 侯婷, 吴玉洁. 益肝宝颗粒治疗非酒精性脂肪肝临床疗效观察. 中医临床研究 2018;10(15):62-3.
|
6 |
马军, 宋雨鸿. 五苓散对非酒精性脂肪肝病患者血清瘦素水平及胰岛素抵抗指数的影响. 光明中医 2018;33(16):2389-92.
|
7 |
莫小艾, 蒋开平, 李建鸿. 受控衰减参数评估黄连温胆汤治疗非酒精性脂肪肝湿热证疗效观察. 深圳中西医结合杂志 2018;28(07):44-6.
|
8 |
费亚军, 费璇. 温阳通络祛浊方治疗非酒精性脂肪肝的疗效及对肝脾CT值的影响. 现代中西医结合杂志 2018;27(24):2699-702.
|
9 |
时晔. 畲药验方降脂保肝饮对非酒精性脂肪肝病痰湿内阻证的疗效研究 [硕士]: 浙江中医药大学 2018.
|
10 |
王震, 张萍, 孙理军, 冯盟盟, 刘鹏. 五苓散加味方治疗痰湿瘀阻型非酒精性脂肪肝疗效观察. 陕西中医药大学学报 2018;41(04):59-60, 70.
|
11 |
张远杰. 自拟肝脂清膏方治疗非酒精性脂肪肝. 吉林中医药 2018;38(04):413-6.
|
12 |
赵嘉晶, 汪颖珏, 朱永新, 高书荣, 岳瑶函. 茵陈蒿汤加减方对非酒精性脂肪肝患者糖、脂及尿酸代谢的影响. 四川中医 2018;36(03):112-4.
|
13 |
周烨威, 王继海, 郑井平, 李伟, 李欢, 赵红. 活血降脂方治疗非酒精性脂肪肝的CT定量疗效评价. 现代中西医结合杂志 2018;27(09):975-7.
|
14 |
崔玉红. 二陈汤加味治疗非酒精性脂肪肝临床疗效观察. 中医临床研究 2018;10(04):59-60.
|
15 |
陶杨, 左玉江, 王东宁, 郝天鹏, 楚二伟, 曲亚罡. 速效降脂舒肝汤治疗非酒精性脂肪肝临床研究. 中医学报 2017;32(03):444-8.
|
16 |
鲁琳, 王青. 水飞蓟宾联合中药治疗非酒精性脂肪肝24例疗效观察. 内蒙古中医药 2017;36(06):27.
|
17 |
鲁恒心. 消脂清肝汤治疗非酒精性脂肪肝痰湿内阻证临床研究. 中医学报 2017;32(12):2477-80.
|
18 |
李萍, 束晓玉. 自拟解郁疏肝汤治疗肝郁气滞型非酒精性脂肪肝临床疗效及作用机制研究. 四川中医 2017;35(01):94-6.
|
19 |
付强. 温胆汤加减治疗单纯性非酒精性脂肪肝血脂异常 (痰湿质) 的临床观察 [硕士]: 长春中医药大学 2017.
|
20 |
王静. 软肝煎治疗非酒精性脂肪肝临床观察. 天津中医药 2017;34(03):168-9.
|
21 |
张铁成, 任亚红. 调脂理肝汤治疗非酒精性脂肪肝的临床观察. 内蒙古中医药 2017;36(Z1):57-8.
|
22 |
周烨威, 王继海, 郑井平, 李伟, 李欢, 曾开胜, et al. 活血降脂方对非酒精性脂肪肝脂质代谢及肝功能影响. 光明中医 2017;32(16):2300-2.
|
23 |
陈延光. 茵芩清肝汤加减方对非酒精性脂肪肝患者血清生化指标及中医症状积分的影响. 四川中医 2017;35(09):66-8.
|
24 |
蔡小旗, 蔡媛媛, 谢红丹. 加减二陈四物汤治疗非酒精性脂肪肝124例临床观察. 世界中医药 2017;12(02):285-8.
|
25 |
李斌. 舒肝消癖颗粒治疗非酒精性脂肪肝的临床疗效观察. 中医临床研究 2017;9(32):48-9.
|
26 |
甘小华, 叶翠河, 欧恺怡, 黄新华. 活血化肝煎治疗非酒精性脂肪肝痰瘀互结型临床研究. 光明中医 2016;31(20):2923-5.
|
27 |
贵襄平. 枳术清脂汤治疗非酒精性脂肪肝42例临床观察. 中西医结合肝病杂志 2016;26(05):300-1.
|
28 |
冀晓利. 化痰降脂饮治疗非酒精性脂肪肝病的疗效分析. 疾病监测与控制 2016;10(07):547-9.
|
29 |
刘启明. 活血降浊方治疗非酒精性脂肪肝病疗效观察. 现代医药卫生 2016;32(09):1385-6.
|
30 |
马红学, 任顺平, 李朝喧, 李佩芳, 雷曙强, 张彦敏. 健脾抑脂方治疗非酒精性脂肪肝40例临床疗效观察. 中国民间疗法 2016;24(11):42-3.
|
31 |
Sourianarayanane A, Pagadala MR, Kirwan JP. Management of non-alcoholic fatty liver disease. Minerva Gastroenterol Dietol 2013;59(1):69-87.
|
32 |
Masuoka HC, Chalasani N. Nonalcoholic fatty liver disease: an emerging threat to obese and diabetic individuals. Ann NY Acad Sci 2013;1281:106-22.
DOI
|
33 |
Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, et al. Harrison' principles of internal medicine. 17th ed. NewYork: McGraw-Hill; 2008, p. 1980-3.
|
34 |
Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, et al. Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol 2006;21:138-43.
DOI
|
35 |
Bae JC, Cho YK, Lee WY, Seo HI, Rhee EJ, Park SE, et al. Impact of nonalcoholic fatty liver disease on insulin resistance in relation to HbA1c levels in nondiabetic subjects. Am J Gastroenterol2010;105(11):2389-95.
DOI
|
36 |
Choi SY, Kim D, Kim HJ, Kang JH, Chung SJ, Park MJ, et al. The relation between non-alcoholic fatty liver disease and the risk of coronary heart disease in Koreans. Am J Gastroenterol2009;104(8):1953-60.
DOI
|
37 |
Argo CK, Caldwell SH. Epidemiology and natural history of non-alcoholic steatohepatitis. Clinics in liver disease2009;13(4):511-31.
DOI
|
38 |
Lee HI, Kim JS, Kim CJ, Kim HN, Yang TJ, Jeong SJ, et al. Research on Anti-lipogenic Effect of Sobuncheong-eum on Experimental Cellular Model of Non-alcoholic Fatty Liver Disease. Herbal Formula Science 2016;24(2):100-7.
DOI
|
39 |
Han CW, Lee JH. Effects of KHchunggan-tang on the Nonalcoholic Fatty Liver Disease in Palmitate-induced Cellular Model. J Korean Oriental Med2011;32(1):109-20.
|
40 |
Lee JW, Choi CW, Jeon SY, Han CW, Ha YJ. Effect of Jungmanbunso-hwan Extract on HepG2 Cell Model of Nonalcoholic Fatty Liver Disease Caused by Palmitate. The Journal of Internal Korean Medicine2016;37(3):442-52.
|
41 |
Kim SY, Kwon JN, Lee I, Hong JW, Choi JY, Park SH, et al. Research on Anti-lipogenic Effect and Underlying Mechanism of Laminaria japonica on Experimental Cellular Model of Non-alcoholic Fatty Liver Disease. J Int Korean Med 2014;35(2):175-83.
|
42 |
万斌, 商洪. 健脾疏肝活血方治疗非酒精性脂肪肝的临床疗效观察. 陕西中医 2016;37(02):135-8.
|
43 |
史晓伟, 王一强, 张玉香, 王俊喹. 清肝祛湿活血方治疗非酒精性脂肪肝的疗效评价. 中国实验方剂学杂志 2016;22(15):181-4.
|
44 |
徐中菊, 王慧, 顾婷婷, 陈宝瑾, 陈雄白. 丹芍疏肝颗粒对不同中医证型非酒精性脂肪肝临床疗效研究. 辽宁中医杂志 2016;43(04):771-3.
|
45 |
杨倩, 张娜, 李鹏, 张云凤, 刘勇涛, 陈宏宇. 柴胡消脂方治疗气滞血瘀型非酒精性脂肪肝性肝病临床研究. 四川中医 2016;34(03):92-3.
|
46 |
阳航, 蔡艳. 清脂化瘀汤治疗非酒精性脂肪肝45例疗效观察. 湖南中医杂志 2016;32(01):41-3.
|
47 |
王家华. 化浊清肝汤应用于非酒精性脂肪肝124例临床疗效探讨. 现代诊断与治疗 2016;27(12):2193-4.
|
48 |
王玉晓, 朱平生. 疏肝消脂方治疗非酒精性脂肪肝31例. 河南中医 2016;36(05):815-7.
|
49 |
王田元. 自拟降脂护肝汤治疗非酒精性脂肪肝30例. 江西中医药 2016;47(06):47-9.
|
50 |
张悦. 健脾疏肝降脂方治疗非酒精性脂肪肝 (肝郁脾虚证) 的临床研究 [硕士]: 河南中医药大学 2016.
|
51 |
丁海荣. 疏肝健脾疗法对非酒精性脂肪肝患者的临床疗效观察 [硕士]: 河北医科大学 2016.
|
52 |
Han CW, Joo MS, Lee JH. Comparison of the Therapeutic Efficacy of Rhizoma Alismatis, Fructus Crataegi, Fructus Lycii, Radix Curcumae, Radix Salviae Miltiorrhizae, Herba Artemisiae Scopariae on the Experimental Cellular Model of Nonalcoholic Fatty Liver Disease. The Journal of Internal Korean Medicine2012;33(4):533-42.
|
53 |
Jang YS, Seo JY, Kwun MJ, Kwon JN, Lee I, Hong JW, et al. Effect of Phaseoulusangularis Seed on Experimental Cellular Model of Nonalcoholic Fatty Liver Desease. Korean J Oreintal Physiology & Pathology2013;27(6):802-8.
|
54 |
Choi JY, Kim SY, Kwun MJ, Kim KH, Joo MS, Han CW. Effects of Ethanol Extract of Benincasa Seeds on the Experimental Cellular Model of Nonalcoholic Fatty Liver Disease. The Journal of Internal Korean Medicine2012; 33(4):438-47.
|
55 |
Ibrahim MA, Kelleni M, Geddawy A. Nonalcoholic fatty liver disease: current and potential therapies. Life Sci 2013;92(2):114-8.
DOI
|
56 |
周毅, 米海霞, 徐苗苗, 林希, 林祥. 复肝消脂汤治疗非酒精性脂肪肝的临床观察. 中国中医药科技 2016;23(05):577-8.
|
57 |
潘孟, 傅萍. 降脂养肝汤治疗痰瘀互结型非酒精性脂肪肝30例. 江西中医药大学学报 2016;28(03):48-50.
|
58 |
Li L, Zhang XJ, Lan Y, Xu L, Zhang XZ, Wang HH. Treatment of non-alcoholic fatty liver disease by Qianggan Capsule. Chin J Integr Med 2010;16(1):23-7.
DOI
|
59 |
Hasegawa T, Yoneda M, Nakamura K, Makino I, Terano A. Plasma transforming growth factor -beta1 level and efficacy of alpha-tocopherol in patients with nonalcoholic steatohepatitis: a pilot study. Aliment Pharmacol Ther 2001;15:1667-72.
DOI
|
60 |
Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2003;98(11):2485-90.
DOI
|
61 |
National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994;89(3):1333-445.
DOI
|
62 |
Li JJ, Lu ZL, Kou WR. Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS). J Clin Pharmacol2009;49(8):947-56.
DOI
|
63 |
Jia YJ, Zhang Y, Liu J, Guo YL, Xu RX, Li JJ. Short- and long-term effects of xuezhikang, an extract of cholestin, on serum proprotein convertase subtilisin/kexin type 9 levels. Chin J Integr Med2016;22(2):96-100.
DOI
|
64 |
Al-Anati L, Essid E, Reinehr R, Petzinger E. Silibinin protects OTA-mediated TNF-alpha release from perfused rat livers and isolated rat Kupff er cells. Mol Nutr Food Res 2009;53(4):460-6.
DOI
|
65 |
Jayaraj R, Deb U, Bhaskar AS, Prasad GB, Rao PV. Hepatoprotective efficacy of certain flavonoids against microcystin induced toxicity in mice. Environ Toxicol 2007;22(5):472-9.
DOI
|
66 |
Loguercio C, Andreone P, Brisc C, Brisc MC, Bugianesi E, Chiaramonte M, et al. Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radical Bio Med2012;52(9):1658-65.
DOI
|
67 |
Jang IW, Jeong JK, Kim HS, Lee SI. The Literature Study of Research Trend of Alismatis Rhizoma and Relationship Between the Herbology and KCD. Kor J Herbol 2016;31(2):47-62.
DOI
|
68 |
Park CH, Kim YS. Effects of Salviae Miltiorrhizae Radix on Blood-Brain Barrier Impairment of ICH-Induced Rats. Kor J Herbology 2014;29(1):19-26.
DOI
|
69 |
Kim HC, Kim HW, Cho SI, Kim YS, Lee JS, Kwon JN, et al. Effects of Salviae miltiorrhizae Radix (SMR) on Serum Lipid Level in Hyperlipidemic Rats. Kor J Herbology 2007;22(4):239-45.
|
70 |
Lee SK, Lee SS, Baek JW, Lee SJ, Kim KH. Effect of CRATAEGII FRUCTUS(山査) on Sarum Lipid in High Cholesterol Diet Induced Hyperlipide Rats. Kor J Oriental Preventive Medical Society2003;7(2):13-22.
|
71 |
Yun HJ, Cha HM, Kim SW, Shin WC, Kim HG, Choe SY. Effects of the Extract of Hoelen on Serum Lipid Profiles in Mice. J Korean Soc Food Sci Nutr2006;35(8):1005-9.
DOI
|
72 |
The National College of Korean Medicine Herbal medicine textbook compilation committee. Korean Herbal Medicine. 2nd ed. Seoul: Yeonglimsa; 2012, p. 12, 344-9, 369-70, 411-2, 458-9.
|